✓ Selected as TIPS (Techn Incubator Program for Ttartups) Program by Ministry of SMBs and Startups of Korea
✓ Development of the PTD-DBM, well acknowledged neogenic hair promoting peptide
✓ The PTD-DBM was recognized by selection as “Top 100 Science Spinoffs in 2017”; Ranked in the top 2% of 5,000 global technology evaluations.

✓ Certified governmental approval as the “Company-Affiliated Research Institute”
✓ Certified as a venture company
✓ Awarded new technology development project
✓ Series A Funding: Synergy IB Investment, Hyundai Technology Investment, Korea Development Bank

✓ MASH project was selected as a New Drug Development Program of Korea National Research Foundation (KNRF)
✓ Development of the drugs for Skin Tissue Regeneration as a  New Drug Development Program of Korea National Research Fund (KNRF).
✓ Awarded skin tissue regeneration drug development project (KHIDI)

✓ Headquarter Relocation in Engineering Complex in Yonsei.
✓ Wound Healing Project was selected as a New Drug Development Program of Korea Health  Industry Development Institute (KHDI)
✓Selected for National Skin Tissue Regeneration Drug Development Program
✓ Alzheimer’s Drug Development Project was selected as a New Drug Development Program of the KNRF.

✓ Renaming of the Company from CK Biotech Ltd. to CK Regeon Inc.
✓ Series B Funding : Korea Development Bank, Yozma Group Korea, Knet Investment Partners, Synergy IB Investment, Biohub
✓ Selected as 2nd TIPS  Program by Ministry of SMBs and Startups of Korea
✓ CEO awarded the Yonsei University Startup Grand Prize.
✓ Featured in Korea Economic Insight as part of a special report: "Latest Trends in Hair Growth Product Development."

✓ CK Regeon Inc. Awarded the Prize from Minister of the Korea Health Industry Development Institute (KHDI).

✓ Approvoal for IND by MFDS for KY19382 (hair grwoth/wound healing)
✓ CEO Awared the Prize for Yonsei START-UP
✓ Introduced CKR’s Hair Promoting Agent Development in Hair Therapy & Transplantation      
✓ Featured in Korea Economic Insight under “Latest Trends in Hair Growth Product Development”
✓ Published in Hair Therapy & Transplantation (Short Communication)
✓ Completion of Phase 1 skin clinical trial for KY19382